» Articles » PMID: 21963514

Nonopioid Placebo Analgesia is Mediated by CB1 Cannabinoid Receptors

Overview
Journal Nat Med
Date 2011 Oct 4
PMID 21963514
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

Placebo analgesia is mediated by both opioid and nonopioid mechanisms, but so far nothing is known about the nonopioid component. Here we show that the specific CB1 cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (rimonabant or SR141716) blocks nonopioid placebo analgesic responses but has no effect on opioid placebo responses. These findings suggest that the endocannabinoid system has a pivotal role in placebo analgesia in some circumstances when the opioid system is not involved.

Citing Articles

Top-down control of the descending pain modulatory system drives placebo analgesia.

Livrizzi G, Liao J, Johnson D, Lubejko S, Chang-Weinberg J, Dong C bioRxiv. 2025; .

PMID: 39990412 PMC: 11844511. DOI: 10.1101/2025.02.13.638185.


Convergent state-control of endogenous opioid analgesia.

Kimmey B, Ejoh L, Shangloo L, Wojick J, Chehimi S, McCall N bioRxiv. 2025; .

PMID: 39803541 PMC: 11722426. DOI: 10.1101/2025.01.03.631111.


Self-regulated analgesia in males but not females is mediated by endogenous opioids.

Dean J, Reyes M, Oliva V, Khatib L, Riegner G, Gonzalez N PNAS Nexus. 2024; 3(10):pgae453.

PMID: 39430222 PMC: 11489871. DOI: 10.1093/pnasnexus/pgae453.


Factors associated with a placebo effect in Parkinson's disease in clinical trials: a meta-analysis.

Haji S, Sako W, Murakami N, Osaki Y, Izumi Y J Neurol. 2024; 271(9):5825-5837.

PMID: 38955829 DOI: 10.1007/s00415-024-12529-4.


The Roles of Endogenous Opioids in Placebo and Nocebo Effects: From Pain to Performance to Prozac.

Kerr P, Gregg J Adv Neurobiol. 2024; 35:183-220.

PMID: 38874724 DOI: 10.1007/978-3-031-45493-6_10.


References
1.
Price D, Finniss D, Benedetti F . A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol. 2007; 59:565-90. DOI: 10.1146/annurev.psych.59.113006.095941. View

2.
Hamza M, Dionne R . Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition. Curr Mol Pharmacol. 2009; 2(1):1-14. PMC: 2749259. DOI: 10.2174/1874467210902010001. View

3.
Benedetti F . Mechanisms of placebo and placebo-related effects across diseases and treatments. Annu Rev Pharmacol Toxicol. 2007; 48:33-60. DOI: 10.1146/annurev.pharmtox.48.113006.094711. View

4.
Benedetti F, Amanzio M, Maggi G . Potentiation of placebo analgesia by proglumide. Lancet. 1995; 346(8984):1231. DOI: 10.1016/s0140-6736(95)92938-x. View

5.
Benedetti F, Pollo A, Colloca L . Opioid-mediated placebo responses boost pain endurance and physical performance: is it doping in sport competitions?. J Neurosci. 2007; 27(44):11934-9. PMC: 6673345. DOI: 10.1523/JNEUROSCI.3330-07.2007. View